Literature DB >> 4118414

Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factor.

A S Rubin, A H Coons.   

Abstract

In short-term cultures of thymocytes from tetanus toxoid-immunized mice, the addition of 1 ng of toxoid generated the release of a soluble factor which was capable of enhancing the immune response to a heterologous immunogen. The addition of supernatants from such cultures to assay cultures of sheep erythrocyte-stimulated normal spleen cells produced a significant augmentation of the hemolytic plaque response. Culture fluid from similar cultures of normal thymocytes or primed thymocytes cultured without the priming antigen were inactive. The enhancing factor was nondialyzable, heat stable (56 degrees C, 30 min), resistant to DNAse and RNAse, but was inactivated by protease. A factor produced by specifically stimulated primed spleen cells had similar characteristics. In toxoid-stimulated, mixed cell cultures containing primed thymocytes or spleen cells and normal spleen cells, tenfold fewer thymocytes than spleen cells were needed to produce a comparable degree of enhancement of the anti-sheep erythrocyte plaque-forming cell response.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4118414      PMCID: PMC2139317          DOI: 10.1084/jem.136.6.1501

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen.

Authors:  A Basten; J F Miller; N L Warner; J Pye
Journal:  Nat New Biol       Date:  1971-05-26

2.  In vitro reconstitution of the immune response of thymus-deprived mice to sheep red blood cells.

Authors:  A Munro; P Hunter
Journal:  Nature       Date:  1970-01-17       Impact factor: 49.962

3.  Immunocompetent cells among mouse thymocytes: a minor population.

Authors:  E Leckband; E A Boyse
Journal:  Science       Date:  1971-06-18       Impact factor: 47.728

4.  Cell interactions in the primary immune response in vitro: a requirement for specific cell clusters.

Authors:  D E Mosier
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

5.  Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice.

Authors:  G J Nossal; A Cunningham; G F Mitchell; J F Miller
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

6.  The requirement of more than one antigenic determinant for immunogenicity.

Authors:  K Rajewsky; V Schirrmacher; S Nase; N K Jerne
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

7.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

8.  Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses.

Authors:  W E Paul; D H Katz; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

9.  Regulation of the secondary antibody response in vitro. Enhancement by actinomycin D and inhibition by a macromolecular product of stimulated lymph node cultures.

Authors:  C T Ambrose
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

10.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  10 in total

1.  Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model.

Authors:  Karin N Westlund; Liping Zhang; Fei Ma; Helieh S Oz
Journal:  Transl Res       Date:  2011-11-08       Impact factor: 7.012

2.  Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.

Authors:  S L McIlwrath; R Nesemeier; F Ma; H S Oz; L Zhang; K N Westlund
Journal:  Eur J Pain       Date:  2017-03-20       Impact factor: 3.931

3.  Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response.

Authors:  A S Rubin
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

4.  Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.

Authors:  G N Douglas; A S Rubin
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

5.  Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.

Authors:  G N Douglas; A S Rubin
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

6.  In vitro anamnestic immune responses and modulating factors.

Authors:  A B Stavitsky; A A Gerblich
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

7.  Partial characterization of an immunoenhancing factor from allogeneic human lymphocyte cell lines.

Authors:  A S Rubin; A B Macdonald
Journal:  Immunology       Date:  1976-01       Impact factor: 7.397

8.  Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes.

Authors:  D Armerding; D H Katz
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

9.  Immunological responses of mice to native protoplasmic polysaccharide and lipopolysaccharide: functional separation of the two signals required to stimulate a secondary antibody response.

Authors:  K B Von Eschen; J A Rudbach
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

10.  Dual regulatory role of the thymus in the maturation of immune response in the rabbit.

Authors:  M Taniguchi; T Tada
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.